Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

Tyrosine kinase inhibitors (TKIs) have dramatically changed the survival of chronic myeloid leukemia (CML) patients, and treatment-free remission (TFR) has recently emerged as a new goal of CML treatment. The aim of this work was to develop recommendations for TKI discontinuation in Latin America (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlovsky, Carolina, Abello Polo, Virginia, Pagnano, Katia, Varela, Ana Ines, Agudelo, Claudia, Bianchini, Michele, Boquimpani, Carla, Centrone, Renato, Conchon, Monica, Delgado, Nancy, Funke, Vaneuza, Giere, Isabel, Luise, Ingrid, Meillon, Luis, Moiraghi, Beatriz, Navarro, Juan Ramon, Pilleux, Lilian, Prado, Ana Ines, Undurraga, Soledad, Cortes, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153024/
https://www.ncbi.nlm.nih.gov/pubmed/34438444
http://dx.doi.org/10.1182/bloodadvances.2020003235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153024/
https://www.ncbi.nlm.nih.gov/pubmed/34438444
http://dx.doi.org/10.1182/bloodadvances.2020003235

Ejemplares similares